Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
6,171
datasets available to search
ShareScore release 0.9.0
Dataset results
6,171 results for “mutant”
Encorafenib, Binimetinib and Cetuximab in Subjects With Previously Untreated BRAF-mutant ColoRectal Cancer
ClinicalTrials.gov study NCT03693170. IPD Sharing: Not stated. Countries: 9. Publications: 1.
A Study of GSK2118436 in BRAF Mutant Metastatic Melanoma to the Brain
ClinicalTrials.gov study NCT01266967. IPD Sharing: Not stated. Countries: 6. Publications: 3.
Re-differentiation of Radioiodine-Refractory BRAF V600E-mutant Papillary Thyroid Carcinoma With GSK2118436
ClinicalTrials.gov study NCT01534897. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study of Avelumab, Binimetinib and Talazoparib in Patients With Locally Advanced or Metastatic RAS-mutant Solid Tumors
ClinicalTrials.gov study NCT03637491. IPD Sharing: NO. Countries: 3. Publications: 2.
Osimertinib in Treating Participants With Stage I-IIIA EGFR-mutant Non-small Cell Lung Cancer Before Surgery
ClinicalTrials.gov study NCT03433469. IPD Sharing: NO. Countries: 1. Publications: 1.
Omacetaxine and Venetoclax for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome Harboring Mutant RUNX1
ClinicalTrials.gov study NCT04874194. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Oleclumab (MEDI9447) Epidermal Growth Factor Receptor Mutant (EGFRm) Non-small Cell Lung Cancer (NSCLC) Novel Combination Study
ClinicalTrials.gov study NCT03381274. IPD Sharing: YES. Countries: 3. Publications: 1.
Pembrolizumab in Treating Patients With EGFR Mutant, Tyrosine Kinase Inhibitor Naive Advanced Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT02879994. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Onalespib, Dabrafenib, and Trametinib in Treating Patients With BRAF-Mutant Melanoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
ClinicalTrials.gov study NCT02097225. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma
ClinicalTrials.gov study NCT01584648. IPD Sharing: Not stated. Countries: 14. Publications: 8.
A Study to Assess the Efficacy and Safety of Lenalidomide in Combination With Cetuximab in Pre-treated Patients With KRAS Mutant Colorectal Cancer
ClinicalTrials.gov study NCT01032291. IPD Sharing: Not stated. Countries: 6. Publications: 2.
Study to Measure Cerebrospinal Fluid Mutant Huntingtin Protein in Participants With Early Manifest Stage I or Stage II Huntington's Disease
ClinicalTrials.gov study NCT03664804. IPD Sharing: Not stated. Countries: 4. Publications: 0.
APR-246 in Combination With Venetoclax and Azacitidine in TP53-Mutant Myeloid Malignancies
ClinicalTrials.gov study NCT04214860. IPD Sharing: NO. Countries: 1. Publications: 1.
Inactivated Poliovirus Vaccine (IPV) With or Without E.Coli Double Mutant Heat-Labile Toxin (dmLT) Challenge Study in Healthy Adults
ClinicalTrials.gov study NCT04232943. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Ivosidenib (AG-120) With Nivolumab in IDH1 Mutant Tumors
ClinicalTrials.gov study NCT04056910. IPD Sharing: NO. Countries: 1. Publications: 2.
Berzosertib and Irinotecan in Treating Patients With Progressive, Metastatic, or Unresectable TP53 Mutant Gastric or Gastroesophageal Junction Cancer
ClinicalTrials.gov study NCT03641313. IPD Sharing: YES. Countries: 1. Publications: 1.
A Phase Ib/II Study of LEE011 in Combination With MEK162 in Patients With NRAS Mutant Melanoma
ClinicalTrials.gov study NCT01781572. IPD Sharing: Not stated. Countries: 5. Publications: 1.
BKM120 Combined With Vemurafenib (PLX4032) in BRAFV600E/K Mutant Advanced Melanoma
ClinicalTrials.gov study NCT01512251. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ABC-lung: Atezolizumab, Bevacizumab and Chemotherapy in EGFR-mutant Non-small Cell Lung Carcinoma
ClinicalTrials.gov study NCT04245085. IPD Sharing: UNDECIDED. Countries: 5. Publications: 1.
An Open-label Study of GSK1120212 Compared With Docetaxel in Stage IV KRAS-mutant Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT01362296. IPD Sharing: Not stated. Countries: 8. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.